secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001193125-24-165735
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus amends stockholders agreement to phase out classified board structure
-------------------------------------------------------------------------------

- Amendment to Stockholders Agreement moves to annual director elections after 2024 annual meeting.
- Existing three-year terms for current directors continue until expiration; successors will serve one-year terms.
- Company authorized to amend charter and bylaws to reflect declassification of the Board.
- Change applies to director designees of Essex and S+N principal stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000119312524165735/0001193125-24-165735-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000119312524165735/d821942d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-165735

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer